Johnson & Johnson quarterly profit jumps 41.8%

Johnson & Johnson quarterly profit jumps 41.8%

J&J on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results. Pharmaceutical sales in the quarter rose 1.7 per cent to $10.53 billion, above analysts’ estimates. Excluding items, the company earned $2.58 per share.

Timothy
Timothy
Miles O'Brien
Miles O'Brien 7 months

Building profits on opiod addicts.

Top in Business
Get the App